rs2074506
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_020442.6(VARS2):c.2038G>T(p.Val680Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.334 in 1,611,656 control chromosomes in the GnomAD database, including 93,509 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.28 ( 6844 hom., cov: 33)
Exomes 𝑓: 0.34 ( 86665 hom. )
Consequence
VARS2
NM_020442.6 missense, splice_region
NM_020442.6 missense, splice_region
Scores
2
16
Splicing: ADA: 0.9522
1
1
Clinical Significance
Conservation
PhyloP100: 4.29
Genes affected
VARS2 (HGNC:21642): (valyl-tRNA synthetase 2, mitochondrial) This gene encodes a mitochondrial aminoacyl-tRNA synthetase, which catalyzes the attachment of valine to tRNA(Val) for mitochondrial translation. Mutations in this gene cause combined oxidative phosphorylation deficiency-20, and are also associated with early-onset mitochondrial encephalopathies. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0024447143).
BP6
Variant 6-30922706-G-T is Benign according to our data. Variant chr6-30922706-G-T is described in ClinVar as [Benign]. Clinvar id is 380157.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.358 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VARS2 | NM_020442.6 | c.2038G>T | p.Val680Leu | missense_variant, splice_region_variant | 22/30 | ENST00000676266.1 | NP_065175.4 | |
VARS2 | NM_001167734.2 | c.2128G>T | p.Val710Leu | missense_variant, splice_region_variant | 22/30 | NP_001161206.1 | ||
VARS2 | NM_001167733.3 | c.1618G>T | p.Val540Leu | missense_variant, splice_region_variant | 21/29 | NP_001161205.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VARS2 | ENST00000676266.1 | c.2038G>T | p.Val680Leu | missense_variant, splice_region_variant | 22/30 | NM_020442.6 | ENSP00000502585 | P3 |
Frequencies
GnomAD3 genomes AF: 0.280 AC: 42592AN: 152058Hom.: 6847 Cov.: 33
GnomAD3 genomes
AF:
AC:
42592
AN:
152058
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.316 AC: 77549AN: 245306Hom.: 13108 AF XY: 0.324 AC XY: 43282AN XY: 133718
GnomAD3 exomes
AF:
AC:
77549
AN:
245306
Hom.:
AF XY:
AC XY:
43282
AN XY:
133718
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.339 AC: 495350AN: 1459482Hom.: 86665 Cov.: 52 AF XY: 0.339 AC XY: 246296AN XY: 726010
GnomAD4 exome
AF:
AC:
495350
AN:
1459482
Hom.:
Cov.:
52
AF XY:
AC XY:
246296
AN XY:
726010
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.280 AC: 42601AN: 152174Hom.: 6844 Cov.: 33 AF XY: 0.281 AC XY: 20908AN XY: 74384
GnomAD4 genome
AF:
AC:
42601
AN:
152174
Hom.:
Cov.:
33
AF XY:
AC XY:
20908
AN XY:
74384
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1317
ALSPAC
AF:
AC:
1419
ESP6500AA
AF:
AC:
440
ESP6500EA
AF:
AC:
2039
ExAC
AF:
AC:
37430
Asia WGS
AF:
AC:
725
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 16, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jul 31, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 51% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 47. Only high quality variants are reported. - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 19, 2016 | - - |
Combined oxidative phosphorylation defect type 20 Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.
MutationTaster
Benign
P;P;P;P
PrimateAI
Benign
T
PROVEAN
Benign
N;.;N
REVEL
Benign
Sift
Benign
T;.;T
Sift4G
Benign
T;T;T
Polyphen
B;.;.
Vest4
MutPred
Gain of catalytic residue at V680 (P = 0.0579);.;.;
MPC
0.50
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at